Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.

Matthias VannesteBart van der HeijCharlotte Elisabeth ChristiaansenChris L BerendsenElisabeth Johanna Margaretha DriessenHarman Maxim Bruins

Published in: World journal of urology (2023)

This study underpins the recommendation of the EAU NMIBC guideline panel that, if needed and in selected patients, second TURBT may be postponed until after BCG induction treatment in pT1HG disease. Also, routine second TURBT can be omitted in pTaHG disease. Data on replacing second TURBT after BCG treatment by routine cystoscopy and cytology appear promising but require further confirmation in prospective studies.

Keyphrases

muscle invasive bladder cancer
high grade
end stage renal disease
low grade
chronic kidney disease
spinal cord injury
clinical practice
newly diagnosed
prognostic factors
big data
combination therapy
artificial intelligence
fine needle aspiration
machine learning